Stay updated on Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The record for the nivolumab and BMS-986205 head-and-neck cancer trial is displayed with its study details, results, and supporting documents. It states that the study was terminated early due to toxicity concerns and is no longer recruiting participants.
    Difference
    68%
    Check dated 2026-11-07T13:16:31.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T14:09:26.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH terminology transition, saying that “Super Intelligence” will be used in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-24T14:33:38.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T14:27:24.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:22:11.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error state with a basic header and a Home button, indicating access is blocked. The content that previously identified the study (institutions, investigators, and trial details) has been removed, leaving only the generic error page text.
    Difference
    21%
    Check dated 2026-09-19T20:40:42.000Z thumbnail image

Stay in the know with updates to Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page.